Journal of the European Society for Gynaecological Endoscopy


Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI 

C. Dielen1, T. Fiers2, S. Somers1, E. Deschepper 3, J. Gerris1

1 UZ Gent, Dept of Reproductive medicine, De Pintelaan 185, 9000 Gent, Belgium
2 UZ Gent, Clinical Pathology dept., De Pintelaan 185, 9000 Gent, Belgium
3 Biostatistical Unit, Ugent. De Pintelaan 185, 9000 Gent, Belgium 


ovarian stimulation, saliva, serum, estradiol, measurement, correlation 

Published online: Oct 25 2017


Aim of the study: To examine saliva- and serum concentrations correlation of estradiol (E2) in women undergoing ovarian hyperstimulation for IVF/ICSI. Saliva measurements could simplify stimulation follow up. A ‘home’ test for E2 could be useful.

Methods: Prospective interventional academic monocentric study at the Centre for Reproductive Medicine of the University Hospital of Ghent, Belgium. Between November 2014 and August 2015 thirty-one patients were included after random selection (inclusion criteria: < 41 years of age, any rank of IVF/ICSI cycle, serum anti-Mùˆllerian hormone concentration ≥ 1 μg/L, treatment completely at the University Hospital.) Measurements took place using immunoassay serum measurements. Estradiol was determined in saliva and serum by LC-MS/MS. At every control, E2 was measured in saliva and serum. Equilibrium analysis on a part of the serum samples took place. Statistic method used is a linear Mixed- Effects model (MIXED) in SPSS.

Results: Statistical analysis shows a strong linear relation between serum and salivary E2, (R2 of 0.75). E2 in equilibrium dialysis and E2 in serum were also strong correlated (R2 of 0.85).

Conclusions: Strong correlation between serum and salivary E2 concentrations was found. Equilibrium dialysis showed good correlation with salivary E2. Saliva can be a good surrogate for free E2 in women undergoing ovarian hyperstimulation. This may create an opportunity to develop a point of care test for measuring E2, in purpose to simplify screening for OHSS risk.